Suppr超能文献

原发性胆汁性肝硬化患者的脂蛋白(a)浓度及表型

Lipoprotein(a) concentration and phenotypes in primary biliary cirrhosis.

作者信息

Romics L, Nemesánszky E, Szalay F, Császár A, Tresch J, Karádi I

机构信息

3rd Department of Internal Medicine, Semmelweis Medical University, Budapest, Hungary.

出版信息

Clin Chim Acta. 1996 Nov 29;255(2):165-71. doi: 10.1016/0009-8981(96)06404-2.

Abstract

We studied a selected group of 39 female patients suffering from primary biliary cirrhosis (PBC). This disease is characterized by typical lipoprotein alterations and elevated concentrations of serum cholesterol. Despite the increased concentration of atherogenic lipoproteins, enhanced atherogenesis is not characteristic of PBC. Serum total cholesterol, triglycerides, HDL2 and HDL3-cholesterol concentrations were measured by enzymatic methods or in combination with precipitation procedures. Apolipoproteins were determined by using immunonephelometric methods. ELISA sandwich method was used for lipoprotein(a) determinations. Apoprotein(a) phenotyping (isoforms) was performed by Western blotting with specific antibodies. The concentrations of serum lipids, lipoproteins and apoproteins (AI, AII and B) were found in the range of earlier investigations. The serum lipoprotein(a) concentration did not differ between the PBC patients and control subjects (10.0/0.1-54/, median 2.55 vs. 11.5/0-75/, median 5.2 mg/dl). In the advanced stages of PBC we found a higher number of patients with low lipoprotein concentration (lower than 1 mg/dl). In patients with shorter durations and milder histological alterations high HDL2 cholesterol subfractions has been detected (stage I = 0.42 +/- 0.18, stage II = 0.53 +/- 0.29 and stage III = 0.62 +/- 0.41 vs. stage IV = 0.26 +/- 0.15 mmol/l, P < 0.05). Despite the elevation of atherogenic lipoproteins, high HDL2-cholesterol and normal lipoprotein(a) concentrations may be one of the reasons why patients with advanced PBC are not placed at increased risk for atherosclerosis.

摘要

我们研究了一组选定的39名患有原发性胆汁性肝硬化(PBC)的女性患者。这种疾病的特征是典型的脂蛋白改变和血清胆固醇浓度升高。尽管致动脉粥样硬化脂蛋白浓度增加,但动脉粥样硬化增强并非PBC的特征。血清总胆固醇、甘油三酯、HDL2和HDL3胆固醇浓度通过酶法或结合沉淀程序进行测量。载脂蛋白通过免疫比浊法测定。ELISA夹心法用于脂蛋白(a)的测定。载脂蛋白(a)表型分析(异构体)通过用特异性抗体进行蛋白质印迹法进行。血清脂质、脂蛋白和载脂蛋白(AI、AII和B)的浓度在早期研究范围内。PBC患者和对照受试者的血清脂蛋白(a)浓度没有差异(10.0/0.1 - 54/,中位数2.55 vs. 11.5/0 - 75/,中位数5.2 mg/dl)。在PBC的晚期阶段,我们发现脂蛋白浓度低(低于1 mg/dl)的患者数量较多。在病程较短且组织学改变较轻的患者中,检测到较高的HDL2胆固醇亚组分(I期 = 0.42 +/- 0.18,II期 = 0.53 +/- 0.29,III期 = 0.62 +/- 0.41 vs. IV期 = 0.26 +/- 0.15 mmol/l,P < 0.05)。尽管致动脉粥样硬化脂蛋白升高,但高HDL2胆固醇和正常脂蛋白(a)浓度可能是晚期PBC患者未处于动脉粥样硬化风险增加状态的原因之一。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验